Axsome Therapeutics (AXSM) Cost of Revenue (2022 - 2026)
Axsome Therapeutics (AXSM) recorded Cost of Revenue of $17.8 million in Q3 2026, up 49.5% from $11.91 million a year earlier and up 31.3% from the prior quarter.
Powered by 
Analysis
Axsome Therapeutics (AXSM) Cost of Revenue (2022 - 2026) Analysis & Trends
On a TTM basis, Axsome Therapeutics' Cost of Revenue came in at $58.42 million as of Sep 30, 2026, up 27.9% year-over-year; for FY2025, it came in at $47.48 million, up 42.6% from FY2024.
- Annual Cost of Revenue has increased for three straight years, with a three-year compound annual growth rate of 109.0% (FY2022 to FY2025).
- Across earlier years, Cost of Revenue came in at $33.3 million in FY2024 (+27.8%), $26.07 million in FY2023 (+401.4%) and $5.2 million in FY2022.
- The Q3 2026 figure is the highest quarterly Cost of Revenue in data going back to Q2 2022.
- On a year-over-year basis, Cost of Revenue has increased for ten consecutive quarters, with growth averaging 40.5% over the last eight quarters.
- Peak year-over-year performance for Cost of Revenue in the last five years was growth of 367.9% in Q2 2023, against a decline of 16.7% in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $13.56 million (Q2 2026), $14.73 million (Q1 2026) and $12.33 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.93 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.10 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.29 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.89 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 2.95 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.79 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.57 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.03 Bn |
| 10 | Axsome Therapeutics | 7.41 Bn | 6.15 Bn | 241.89 Mn | 17.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 17.80 Mn |
| Jun 30, 2026 | 13.56 Mn |
| Mar 31, 2026 | 14.73 Mn |
| Dec 31, 2025 | 12.33 Mn |
| Sep 30, 2025 | 11.91 Mn |
| Jun 30, 2025 | 13.45 Mn |
| Mar 31, 2025 | 9.79 Mn |
| Dec 31, 2024 | 10.51 Mn |
| Sep 30, 2024 | 8.44 Mn |
| Jun 30, 2024 | 8.06 Mn |
| Mar 31, 2024 | 6.30 Mn |
| Dec 31, 2023 | 7.38 Mn |
| Sep 30, 2023 | 6.53 Mn |
| Jun 30, 2023 | 4.60 Mn |
| Mar 31, 2023 | 7.56 Mn |
| Dec 31, 2022 | 2.29 Mn |
| Sep 30, 2022 | 1.92 Mn |
| Jun 30, 2022 | 983,000.00 |
API Access
Axsome Therapeutics Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=AXSM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "AXSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=AXSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();